Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;120(1):76-79.
doi: 10.1111/vox.13762. Epub 2024 Oct 30.

The safety of pathogen-reduced platelet transfusions in critically ill term and preterm neonates

Alexia D'hont  1   2 , Ginette M Ecury-Goossen  1 , Ruben J Overduin  3 , Meindert E Manshande  1 , Ashley J Duits  4
Affiliations

The safety of pathogen-reduced platelet transfusions in critically ill term and preterm neonates

Alexia D'hont et al. Vox Sang. 2025 Jan.

Abstract

Background and objectives: Platelet transfusions carry an important risk of infection transmission. The Mirasol Pathogen Reduction Technology system for platelets uses riboflavin and UV light to introduce irreparable lesions into nucleic acids, thereby inhibiting pathogen replication and inactivating white blood cells. The objective of this study is to evaluate the safety of pathogen-reduced platelet transfusions (PRPTs) in critically ill infants in a neonatal intensive care unit (NICU) in the Caribbean.

Materials and methods: We conducted a descriptive retrospective study of the use of Mirasol PRPTs in patients admitted to the NICU of the general hospital in Curaçao from February 2016 to April 2023.

Results: A total of 208 PRPTs were administered to 46 patients (median [range] transfusions per patient: 3 [1-24]). Three patients were born term, and 43 were born preterm (median [range] gestational age: 27 4/7 weeks [24 6/7-36 6/7]). PRPTs were well-tolerated and no complications occurred, especially no signs of haemolysis nor any signs of new infection within 24 h after transfusion. Twenty-one of 46 patients (46%) died during their admittance. None of the deaths were deemed related to PRPT.

Conclusion: Mirasol PRPT appears to be safe for use in critically ill neonates, including extremely preterm neonates.

Keywords: neonate; pathogen reduced platelet transfusion.

PubMed Disclaimer

References

REFERENCES

    1. Levy JH, Neal MD, Herman JH. Bacterial contamination of platelets for transfusion: strategies for prevention. Crit Care. 2018;22:271.
    1. Aubron C, Flint AW, Bailey M, Pilcher D, Cheng AC, Hegarty C, et al. Is platelet transfusion associated with hospital‐acquired infections in critically ill patients? Crit Care. 2017;21:2.
    1. Marschner S, Goodrich R. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother. 2011;38:8–18.
    1. Lu W, Fung M. Platelets treated with pathogen reduction technology: current status and future direction. F1000Res. 2020;9:40.
    1. Reikvam H, Marschner S, Apelseth TO, Goodrich R, Hervig T. The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. Blood Transfus. 2010;8:186–192.

LinkOut - more resources